Skip to main content
. 2019 Jul 12;25(6):296–303. doi: 10.5761/atcs.oa.18-00293

Table 1. Demographic data and preoperative characteristics between groups.

Group 1 (n = 28) Group 2 (n = 20) P value

Age, year 61.5 ± 7.7 62.3 ± 7.6 0.72
Sex, male, n (%) 20 (71.4) 13 (65) 0.75
HT, n (%) 20 (71.4) 20 (100) 0.008
DM, n (%) 13 (46.4) 9 (45) 0.924
Hyperlipidemia, n (%) 11 (39.3) 11 (55) 0.291
COPD, n (%) 5 (17.9) 5 (25) 0.558
Obesity, n (%) 3 (10.7) 3 (15) 0.68
PAD, n (%) 4 (14.3) 2 (10) 1.00
CAD, n (%) 4 (14.3) 2 (10) 1.00
LV-EF, % 55.3 ± 7.6 59.7 ± 5.9 0.034
Urea, mg/dL 43.8 ± 17.4 37.5 ± 15.9 0.207
Creatinine, mg/dL 1.2 ± 0.7 0.96 ± 0.4 0.205
New myocardial infarct, n (%) 6 (21.4) 4 (20) 0.907
FEV1, % 83.1 ± 23.8 93.7 ± 22.3 0.151
FVC, % 79.4 ± 22.4 86.8 ± 21.1 0.289
FEF 25–75, % 85.8 ± 34.4 105.2 ± 37.6 0.095

Values are mean ± SD. CAD: carotid artery disease; COPD: chronic obstructive pulmonary disease; DM: diabetes mellitus; FEF 25–75: forced expiratory flow; FVC: forced vital capacity; FEV1: forced expiratory volume in one second; HT: hypertension; LV-EF: left ventricular ejection fraction; PAD: peripheral artery disease